Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US5965522

Title:Stem cell factor formulations and methods
Inventors:Hershenson, SUSA
n I.; Newbury Park, CA, USA
Summary:This invention introduces novel lyophilized stem cell factor formulations, methods and uses thereof. The lyophilized formulations are described as having a pH between 5.0 and 6.0, and containing histidine, glutamic acid, sucrose and mannitol. Claimed advantages of the invention include increased stability and prolonged shelf-life.
Abstract:The invention relates to a novel formulation of stem cell factor. The formulation contains histidine, glutamic acid, sucrose and mannitol. The formulation has a pH between 5.0 and 6.0 and has been lyophilized.
US Patent Website:Click Here for Full Text of Patent
Title Number:US5965522
Application Number:US1998000106891
Date Filed:29/06/1998
Date Published:12/10/1999
Assignee:Amgen Inc., Thousand Oaks, CA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/23/2021